Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.72 USD | +0.47% | +2.06% | +41.77% |
05-10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
05-09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.77% | 3.98B | |
+30.75% | 49.46B | |
+1.16% | 42.58B | |
+49.11% | 42.49B | |
-5.26% | 29.09B | |
+12.78% | 26.61B | |
-23.76% | 18.64B | |
+7.38% | 13.16B | |
+31.42% | 12.55B | |
+23.46% | 12.1B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Citigroup Initiates Crinetics Pharmaceuticals With Buy Rating, $68 Price Target